FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug ...

Ocaliva, approved for primary biliary cholangitis, faced FDA warnings and restrictions after postmarket data showed higher ...

Nordisk and Eli Lilly are set to reshape the oral GLP-1 market as patient demand grows and new therapies emerge. Learn more ...

It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists like Ozempic®, Wegovy®, Mounjaro®, and Zepbound®. While Ozempic can be ...

Certain foods and drinks, such as processed foods, dairy, and alcohol, should not be mixed with honey.

Tax credits made ACA plans affordable for middle-class families. They're set to expire at the end of this year.